Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Pain in Pediatric Thoracoscopic Surgery
NCT06710405Phase 4Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Face, Legs, Activity, Cry, Consolability Scale Score. Started Dec 2024; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06710405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710405.